California’s top marijuana regulator says the Drug Enforcement Administration (DEA) hasn’t been cooperative in answering questions about the implications of the Trump administration’s rescheduling move—while the federal agency is simultaneously asking the state itself to share more information about its medical cannabis program.
“We have received no formal updates from DEA headquarters on implementation guidance of the order,” California Department of Cannabis Control Director Clint Kellum said at a meeting of the Cannabis Advisory Committee on Tuesday.
“We have been trying to communicate with DEA headquarters to get a better understanding of what their expectations rule set will be for operators under the guidance,” he said. “Unfortunately, to date, we have not been offered any information on that front.”
Kellum said that there have been “national-level efforts” to contact DEA in conjunction with cannabis regulators from other states, but they “just really haven’t seen any sort of interest on that front, unfortunately.”
The California official said that regulators are waiting for further guidance from the feds before they make further changes to state rules related to marijuana’s evolving federal legal status.
“The last thing what we want to do is try to be guessing what they’re going to be doing,
Read full article on Marijuana Moment
